{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T14:49:22Z","timestamp":1791557362747,"version":"4.3.4"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2012,8,18]],"date-time":"2012-08-18T00:00:00Z","timestamp":1345248000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Diabetologia"],"published-print":{"date-parts":[[2012,11]]},"DOI":"10.1007\/s00125-012-2679-x","type":"journal-article","created":{"date-parts":[[2012,8,16]],"date-time":"2012-08-16T22:47:40Z","timestamp":1345157260000},"page":"3071-3082","source":"Crossref","is-referenced-by-count":6,"title":["Mechanisms of antihyperglycaemic action of efaroxan in mice: time for reappraisal of \u03b12A-adrenergic antagonism in the treatment of type 2 diabetes?"],"prefix":"10.1007","volume":"55","author":[{"given":"Z.","family":"Lehner","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Stadlbauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.","family":"Adorjan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.","family":"Rustenbeck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Belz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Fenzl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V. A. M.","family":"de Cillia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Gruber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Bauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Frobel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Brunmair","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Luger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"F\u00fcrnsinn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,8,18]]},"reference":[{"key":"2679_CR1","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1126\/science.1176827","volume":"327","author":"AH Rosengren","year":"2010","unstructured":"Rosengren AH, Jokubka R, Tojjar D et al (2010) Overexpression of alpha2A-adrenergic receptors contributes to type 2 diabetes. Science 327:217\u2013220","journal-title":"Science"},{"key":"2679_CR2","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1038\/ng.520","volume":"42","author":"J Dupuis","year":"2010","unstructured":"Dupuis J, Langenberg C, Prokopenko I et al (2010) New genetic loci implicated in fasting glucose homeostasis and their impact on type 2 diabetes risk. Nat Genet 42:105\u2013116","journal-title":"Nat Genet"},{"key":"2679_CR3","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1007\/s00125-010-1753-5","volume":"53","author":"TW Boesgaard","year":"2010","unstructured":"Boesgaard TW, Grarup N, Jorgensen T et al (2010) Variants at DGKB\/TMEM195, ADRA2A, GLIS3 and C2CD4B loci are associated with reduced glucose-stimulated beta cell function in middle-aged Danish people. Diabetologia 53:1647\u20131655","journal-title":"Diabetologia"},{"key":"2679_CR4","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1111\/j.1742-7843.2011.00699.x","volume":"108","author":"V Fagerholm","year":"2011","unstructured":"Fagerholm V, Haaparanta M, Scheinin M (2011) \u03b12-Adrenoceptor regulation of blood glucose homeostasis. Basic Clin Pharmacol Toxicol 108:365\u2013370","journal-title":"Basic Clin Pharmacol Toxicol"},{"key":"2679_CR5","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1016\/S0022-3565(25)12647-5","volume":"254","author":"I Angel","year":"1990","unstructured":"Angel I, Niddam R, Langer SZ (1990) Involvement of alpha-2 adrenergic receptor subtypes in hyperglycemia. J Pharmacol Exp Ther 254:877\u2013882","journal-title":"J Pharmacol Exp Ther"},{"key":"2679_CR6","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1056\/NEJMcibr0911499","volume":"362","author":"FM Gribble","year":"2010","unstructured":"Gribble FM (2010) \u03b12A-Adrenergic receptors and type 2 diabetes. N Engl J Med 362:361\u2013362","journal-title":"N Engl J Med"},{"key":"2679_CR7","doi-asserted-by":"crossref","first-page":"12ps15","DOI":"10.1126\/scitranslmed.3000606","volume":"1","author":"SB Liggett","year":"2009","unstructured":"Liggett SB (2009) \u03b12A-Adrenergic receptors in the genetics, pathogenesis, and treatment of type 2 diabetes. Sci Transl Med 1:12\u201315","journal-title":"Sci Transl Med"},{"key":"2679_CR8","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.cmet.2009.12.002","volume":"11","author":"J Wess","year":"2010","unstructured":"Wess J (2010) More is not always better: \u03b12A-adrenoceptor expression in type 2 diabetes. Cell Metab 11:3\u20135","journal-title":"Cell Metab"},{"key":"2679_CR9","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1172\/JCI108338","volume":"57","author":"RP Robertson","year":"1976","unstructured":"Robertson RP, Halter JB, Porte D (1976) A role for alpha-adrenergic receptors in abnormal insulin secretion in diabetes mellitus. J Clin Invest 57:791\u2013795","journal-title":"J Clin Invest"},{"key":"2679_CR10","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/0026-0495(70)90055-7","volume":"19","author":"MG Buse","year":"1970","unstructured":"Buse MG, Johnson AH, Kuperminc D, Buse J (1970) Effect of \u03b1-adrenergic blockade on insulin secretion in man. Metabolism 19:219\u2013225","journal-title":"Metabolism"},{"key":"2679_CR11","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.2174\/1381612013397366","volume":"7","author":"NG Morgan","year":"2001","unstructured":"Morgan NG, Chan SLF (2001) Imidazoline binding sites in the endocrine pancreas: can they fulfill their potential as targets for the development of new insulin secretagogues? Curr Pharm Des 7:1413\u20131431","journal-title":"Curr Pharm Des"},{"key":"2679_CR12","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1210\/jcem-67-5-1054","volume":"67","author":"C-G \u00d6stenson","year":"1988","unstructured":"\u00d6stenson C-G, Pigon J, Doxey JC, Efendic S (1988) \u03b12-Adrenoceptor blockade does not enhance glucose-induced insulin release in normal subjects or patients with noninsulin-dependent diabetes. J Clin Endocrinol Metab 67:1054\u20131059","journal-title":"J Clin Endocrinol Metab"},{"key":"2679_CR13","first-page":"321","volume":"340","author":"A Schulz","year":"1989","unstructured":"Schulz A, Hasselblatt A (1989) An insulin-releasing property of imidazoline derivatives is not limited to compounds that block \u03b1-adrenoceptors. Naunyn Schmiedebergs Arch Pharmacol 340:321\u2013327","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"2679_CR14","first-page":"637","volume":"337","author":"A Schulz","year":"1988","unstructured":"Schulz A, Hasselblatt A (1988) Phentolamine, a deceptive tool to investigate sympathetic nervous control of insulin release. Naunyn Schmiedebergs Arch Pharmacol 337:637\u2013643","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"2679_CR15","doi-asserted-by":"crossref","first-page":"11716","DOI":"10.1073\/pnas.94.21.11716","volume":"94","author":"P Proks","year":"1997","unstructured":"Proks P, Ashcroft FM (1997) Phentolamine block of KATP channels is mediated by Kir6.2. Proc Natl Acad Sci USA 94:11716\u201311720","journal-title":"Proc Natl Acad Sci USA"},{"key":"2679_CR16","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/S0014-5793(99)00264-1","volume":"447","author":"LK Monks","year":"1999","unstructured":"Monks LK, Cosgrove KE, Dunne MJ, Ramsden CA, Morgan NG, Chan SLF (1999) Affinity isolation of imidazoline binding proteins from rat brain using 5-amino-efaroxan as a ligand. FEBS Lett 447:61\u201364","journal-title":"FEBS Lett"},{"key":"2679_CR17","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1124\/jpet.109.152751","volume":"331","author":"K Hatlapatka","year":"2009","unstructured":"Hatlapatka K, Wienbergen A, K\u00fchne C, J\u00f6rns A, Willenborg M, Rustenbeck I (2009) Selective enhancement of nutrient-induced insulin secretion by ATP-sensitive K+ channel-blocking imidazolines. J Exp Ther Pharmacol 331:1033\u20131041","journal-title":"J Exp Ther Pharmacol"},{"key":"2679_CR18","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1111\/j.1476-5381.2009.00588.x","volume":"159","author":"A Szollosi","year":"2010","unstructured":"Szollosi A, Nenquin M, Henquin JC (2010) Pharmacological stimulation and inhibition of insulin secretion in mouse islets lacking ATP-sensitive K+ channels. Br J Pharmacol 159:669\u2013677","journal-title":"Br J Pharmacol"},{"key":"2679_CR19","doi-asserted-by":"crossref","first-page":"340","DOI":"10.2337\/diabetes.50.2.340","volume":"50","author":"SLF Chan","year":"2001","unstructured":"Chan SLF, Mourtada M, Morgan NG (2001) Characterization of a KATP channel-independent pathway involved in potentiation of insulin secretion by efaroxan. Diabetes 50:340\u2013347","journal-title":"Diabetes"},{"key":"2679_CR20","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1111\/j.1748-1716.2008.01896.x","volume":"195","author":"S Meidute-Abaraviciene","year":"2009","unstructured":"Meidute-Abaraviciene S, Mosen H, Lundquist I, Salehi A (2009) Imidazoline-induced amplification of glucose- and carbachol-stimulated insulin release includes a marked suppression of islet nitric oxide generation in the mouse. Acta Physiol 195:375\u2013383","journal-title":"Acta Physiol"},{"key":"2679_CR21","doi-asserted-by":"crossref","first-page":"2985","DOI":"10.1007\/s00018-007-7308-3","volume":"64","author":"VV Sharoyko","year":"2007","unstructured":"Sharoyko VV, Zaitseva II, Leibiger B, Efendic S, Berggren P-O, Zaitsev SV (2007) Arachnidonic acid signaling is involved in the mechanism of imidazoline-induced KATP channel-independent stimulation of insulin secretion. Cell Mol Life Sci 64:2985\u20132993","journal-title":"Cell Mol Life Sci"},{"issue":"Suppl 3","key":"2679_CR22","doi-asserted-by":"crossref","first-page":"S448","DOI":"10.2337\/diabetes.51.2007.S448","volume":"51","author":"S Efendic","year":"2002","unstructured":"Efendic S, Efanov AM, Berggren P-O, Zaitsev SV (2002) Two generations of insulinotropic imidazoline compounds. Diabetes 51(Suppl 3):S448\u2013S454","journal-title":"Diabetes"},{"key":"2679_CR23","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/0014-2999(92)90683-U","volume":"213","author":"TL Berridge","year":"1992","unstructured":"Berridge TL, Doxey JC, Roach AG, Smith CFC (1992) Selectivity profile of the \u03b12-adrenoceptor antagonist efaroxan in relation to plasma glucose and insulin levels in the rat. Eur J Pharmacol 213:205\u2013212","journal-title":"Eur J Pharmacol"},{"key":"2679_CR24","doi-asserted-by":"crossref","first-page":"2567","DOI":"10.1007\/s00125-005-0031-4","volume":"48","author":"C Bleck","year":"2005","unstructured":"Bleck C, Wienbergen A, Rustenbeck I (2005) Essential role of the imidazoline moiety in the insulinotropic effect but not the KATP channel-blocking effect of imidazolines; a comparison of the effects of efaroxan and its imidazole analogue, KU14R. Diabetologia 48:2567\u20132575","journal-title":"Diabetologia"},{"key":"2679_CR25","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/0014-2999(93)90577-5","volume":"230","author":"SLF Chan","year":"1993","unstructured":"Chan SLF, Brown CA, Morgan NG (1993) Stimulation of insulin secretion by the imidazoline \u03b12-adrenoceptor antagonist efaroxan is mediated by a novel, stereoselective, binding site. Eur J Pharmacol 230:375\u2013378","journal-title":"Eur J Pharmacol"},{"key":"2679_CR26","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1038\/sj.bjp.0701172","volume":"121","author":"M Mourtada","year":"1997","unstructured":"Mourtada M, Brown CA, Smith SA, Piercy V, Chan SLF, Morgan NG (1997) Interactions between imidazoline compounds and sulphonylureas in the regulation of insulin secretion. Br J Pharmacol 121:799\u2013805","journal-title":"Br J Pharmacol"},{"key":"2679_CR27","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1111\/j.1476-5381.1990.tb12099.x","volume":"101","author":"TD Plant","year":"1990","unstructured":"Plant TD, Henquin JC (1990) Phentolamine and yohimbine inhibit ATP-sensitive K+ channels in mouse pancreatic \u03b2-cells. Br J Pharmacol 101:115\u2013120","journal-title":"Br J Pharmacol"},{"key":"2679_CR28","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/BF00656997","volume":"391","author":"OP Hamill","year":"1981","unstructured":"Hamill OP, Marty A, Neher E, Sakmann B, Sigworth FJ (1981) Improved patch-clamp techniques for high-resolution current recordings from cells and cell-free membrane patches. Pfl\u00fcgers Arch 391:85\u2013100","journal-title":"Pfl\u00fcgers Arch"},{"key":"2679_CR29","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/0014-5793(88)80925-6","volume":"239","author":"BJ Z\u00fcnkler","year":"1988","unstructured":"Z\u00fcnkler BJ, Lins S, Ohno-Shosaku T, Panten U (1988) Cytosolic ADP enhances the sensitivity to tolbutamide of ATP-dependent K+-channels from pancreatic B cells. FEBS Lett 239:241\u2013244","journal-title":"FEBS Lett"},{"key":"2679_CR30","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1017\/S1461145709991088","volume":"13","author":"JM Dwyer","year":"2010","unstructured":"Dwyer JM, Platt BJ, Sukoff Rizzo SJ et al (2010) Preclinical characterization of BRL44408: antidepressant- and analgesic-like activity through selective \u03b12A-adrenoceptor antagonism. Int J Neuropsychopharmacol 13:1193\u20131205","journal-title":"Int J Neuropsychopharmacol"},{"key":"2679_CR31","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1677\/jme.1.01764","volume":"35","author":"X Hu","year":"2005","unstructured":"Hu X, Friedman D, Hill S et al (2005) Proteomic exploration of pancreatic islets in mice null for the \u03b12A adrenergic receptor. J Mol Endocrinol 35:73\u201388","journal-title":"J Mol Endocrinol"},{"key":"2679_CR32","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1111\/j.1469-7793.1999.00717.x","volume":"521","author":"S G\u00f6pel","year":"1999","unstructured":"G\u00f6pel S, Kanno T, Barg S, Galvanovskis J, Rorsman P (1999) Voltage-gated and resting membrane currents recorded from B cells in intact mouse pancreatic islets. J Physiol 521:717\u2013728","journal-title":"J Physiol"},{"key":"2679_CR33","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1007\/BF00657506","volume":"407","author":"G Trube","year":"1986","unstructured":"Trube G, Rorsman P, Ohno-Shosaku T (1986) Opposite effects of tolbutamide and diazoxide on the ATP-dependent K+ channel in mouse pancreatic beta-cells. Pfl\u00fcgers Arch 407:493\u2013499","journal-title":"Pfl\u00fcgers Arch"},{"issue":"Suppl 3","key":"2679_CR34","doi-asserted-by":"crossref","first-page":"S135","DOI":"10.2337\/diabetes.53.suppl_3.S135","volume":"53","author":"C Bleck","year":"2004","unstructured":"Bleck C, Wienbergen A, Rustenbeck I (2004) Glucose dependence of imidazoline-induced insulin secretion: different characteristics of two ATP-sensitive K+ channel-blocking compounds. Diabetes 53(Suppl 3):S135\u2013S139","journal-title":"Diabetes"},{"key":"2679_CR35","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/0014-2999(94)90639-4","volume":"264","author":"J-C Jonas","year":"1994","unstructured":"Jonas J-C, Garcia-Barrado M-J, Angel I, Henquin J-C (1994) The imidazoline SL 84.0418 shows stereoselectivity in blocking \u03b12-adrenoceptors but not ATP-sensitive K+ channels in pancreatic B cells. Eur J Pharmacol 264:81\u201384","journal-title":"Eur J Pharmacol"},{"key":"2679_CR36","unstructured":"Chapleo CB, Doxey JC, Stillings MR, inventors; Reckitt & Colman Products, assignee. Imidazoline derivatives. Great Britain patent WO 92\/05171. 1992 2 April"},{"key":"2679_CR37","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1038\/bjp.2008.186","volume":"154","author":"V Fagerholm","year":"2008","unstructured":"Fagerholm V, Scheinin M, Haaparanta M (2008) \u03b12A-Adrenoceptor antagonism increases insulin secretion and synergistically augments the insulinotropic effect of glibenclamide in mice. Br J Pharmacol 154:1287\u20131296","journal-title":"Br J Pharmacol"},{"key":"2679_CR38","doi-asserted-by":"crossref","unstructured":"Ruohonen ST, Ruohonen S, Gilsbach R, Savontaus E, Scheinin M, Hein L (2011) Involvement of \u03b12-adrenoceptor subtypes A and C in glucose homeostasis and adrenaline-induced hyperglycaemia. Neuroendocrinology. doi: 10.1159\/000334629","DOI":"10.1159\/000334629"},{"key":"2679_CR39","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1016\/S0306-4522(98)00392-3","volume":"89","author":"S Tellez","year":"1999","unstructured":"Tellez S, Colpaert F, Marien M (1999) \u03b12-Adrenoceptor modulation of cortical acetylcholine release in vivo. Neuroscience 89:1041\u20131050","journal-title":"Neuroscience"},{"key":"2679_CR40","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1016\/S0022-3565(24)38022-X","volume":"288","author":"P Chopin","year":"1999","unstructured":"Chopin P, Colpaert FC, Marien M (1999) Effects of alpha-2 adrenoceptor agonists and antagonists on circling behavior in rats with unilateral 6-hydroxydopamine lesions of the nigrostriatal pathway. J Pharmacol Exp Ther 288:798\u2013804","journal-title":"J Pharmacol Exp Ther"},{"key":"2679_CR41","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1038\/clpt.1994.35","volume":"55","author":"I Berlin","year":"1994","unstructured":"Berlin I, Rosenzweig P, Chalon S et al (1994) Reduction of hyperglycemia after oral glucose load by the new alpha 2-adrenergic receptor antagonist SL 84.0418 in healthy subjects. Clin Pharmacol Ther 55:338\u2013345","journal-title":"Clin Pharmacol Ther"},{"key":"2679_CR42","doi-asserted-by":"crossref","first-page":"216","DOI":"10.2337\/diabetes.36.2.216","volume":"36","author":"S Kawazu","year":"1987","unstructured":"Kawazu S, Suzuki M, Negishi K, Watanabe T, Ishii J (1987) Studies of midaglizole (DG-5128). A new type of oral hypoglycemic drug in healthy subjects. Diabetes 36:216\u2013220","journal-title":"Diabetes"},{"key":"2679_CR43","doi-asserted-by":"crossref","first-page":"221","DOI":"10.2337\/diabetes.36.2.221","volume":"36","author":"S Kawazu","year":"1987","unstructured":"Kawazu S, Suzuki M, Negishi K et al (1987) Initial phase II clinical studies on midaglizole (DG-5128). A new hypoglycemic agent. Diabetes 36:221\u2013226","journal-title":"Diabetes"},{"key":"2679_CR44","first-page":"E57","volume":"274","author":"A Natali","year":"1998","unstructured":"Natali A, Gastadelli A, Galvan AQ et al (1998) Effects of acute \u03b12-blockade on insulin action and secretion in humans. Am J Physiol 274:E57\u2013E64","journal-title":"Am J Physiol"},{"key":"2679_CR45","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/S0014-2999(02)02473-1","volume":"454","author":"G Mayer","year":"2002","unstructured":"Mayer G, Taberner PV (2002) Effects of the imidazoline ligands efaroxan and KU14R on blood glucose homeostasis in the mouse. Eur J Pharmacol 454:95\u2013102","journal-title":"Eur J Pharmacol"},{"key":"2679_CR46","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1006\/phrs.2001.0870","volume":"44","author":"AO Abdel-Zaher","year":"2001","unstructured":"Abdel-Zaher AO, Ahmed IT, El-Koussi AD (2001) The potential antidiabetic activity of some alpha-2 adrenoceptor antagonists. Pharmacol Res 44:397\u2013409","journal-title":"Pharmacol Res"},{"key":"2679_CR47","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1124\/jpet.103.050468","volume":"306","author":"RA Veliquette","year":"2003","unstructured":"Veliquette RA, Ernsberger P (2003) The role of I1-imidazoline and \u03b12-adrenergic receptors in the modulation of glucose metabolism in the spontaneously hypertensive obese rat model of metabolic syndrome X. J Pharmacol Exp Ther 306:646\u2013657","journal-title":"J Pharmacol Exp Ther"},{"key":"2679_CR48","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1007\/s001250051467","volume":"43","author":"JC Devedjian","year":"2000","unstructured":"Devedjian JC, Pujol A, Cayla C et al (2000) Transgenic mice overexpressing \u03b12A-adrenoceptors in pancreatic beta-cells show altered regulation of glucose homeostasis. Diabetologia 43:899\u2013906","journal-title":"Diabetologia"}],"container-title":["Diabetologia"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00125-012-2679-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00125-012-2679-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00125-012-2679-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,6]],"date-time":"2025-04-06T23:02:16Z","timestamp":1743980536000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00125-012-2679-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,8,18]]},"references-count":48,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2012,11]]}},"alternative-id":["2679"],"URL":"https:\/\/doi.org\/10.1007\/s00125-012-2679-x","relation":{},"ISSN":["0012-186X","1432-0428"],"issn-type":[{"value":"0012-186X","type":"print"},{"value":"1432-0428","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,8,18]]}}}